SIGNAL Brief · weekly · by application

What 200+ operators got wrong — and the numbers behind the patterns.

The Revenue Intelligence briefing. Weekly. Free — but by application only. Read by a curated room of PE operating partners and multi-location healthcare operators who want to see the patterns before they become problems.

SIGNAL is the brief a CFO forwards to a COO. Patterns we surface inside Revenue Lens engagements that would never make it into a marketing newsletter — dormancy concentration trends, attribution drift cases, EU institutional opening windows, AI-revenue-system architectures. Data and structure, not opinions.

Free · by application · reviewed weekly. No spam. Unsubscribe anytime. Your data is never sold or shared. GDPR-compliant.

200+
Audits feeding the brief's pattern library
$72M
Anchor case · patterns from this engagement appear quarterly
$135.6M
Revenue generated across founders' books of work
Friday
07:00 CET · in your inbox · 4-min read
Who reads SIGNAL Brief

Operators, investors, and founders who can't afford a generic newsletter.

Reader · 01

PE Operating Partner

Healthcare-focused funds. Reads SIGNAL when a portco's referral line goes flat and the next board cycle is 6 weeks out. Forwards the brief to portco CFOs and CEOs.

Reader · 02

Mid-size healthcare operator

$5M–$150M revenue. Multi-location home care, DSO, senior living, medspa, hospice. Reads SIGNAL because no other intelligence source actually understands the structural problem.

Reader · 03

MedTech founder

Non-EU companies entering Europe. Reads SIGNAL for the EU institutional-access patterns — VLAIO program shifts, Horizon Europe opening windows, EIT Health partner calls.

Subscribe · free · by application

If the patterns are interesting, your subscription is silent.

SIGNAL is free, but we keep the room curated — apply and we'll review it this week. You'll get one email Friday morning. If you ever stop opening it, we'll quietly assume you've moved on. We don't pitch you in the brief — that's not why people read it.

Free · by application · reviewed weekly. No spam. Unsubscribe anytime. Your data is never sold or shared.

FAQ · SIGNAL Brief

Direct answers.

What is the SIGNAL Brief?

SIGNAL Brief is a free weekly Revenue Intelligence briefing from Innovation Park. Patterns surfaced inside Revenue Lens engagements that would not appear in a marketing newsletter: dormancy concentration trends, attribution drift cases, EU institutional opening windows, AI revenue system architectures. Data and structure, not opinions.

Who reads SIGNAL?

PE Operating Partners at healthcare-focused funds, mid-size healthcare operators ($5M–$150M revenue, multi-location home care, DSO, senior living, medspa, hospice), and non-EU medtech founders entering Europe. The brief is structured for readers who manage partnership and referral revenue lines directly.

How often does it publish and when does it arrive?

Weekly. Friday morning, 07:00 CET. 4-minute read. Four sections: Pattern of the Week, Numbers from the Dataset, A Door That Just Opened (EU institutional opening or regulatory shift), and What We Built Last Week (a workflow, prompt, AI agent, or board-pack template).

Is there a cost? Is data shared?

SIGNAL is free — but by application only. We keep the list curated to the operators, investors, and founders the patterns are actually written for, so the room stays useful and the content stays candid. There is no paid tier. Subscriber data is GDPR-compliant, never sold, never shared. Unsubscribe anytime — and if you stop opening it, we quietly assume you have moved on.

Why is it by application?

Because SIGNAL surfaces anonymized patterns from live engagements, we curate who receives it — PE operating partners, mid-size healthcare operators, and non-EU founders entering Europe. Applications are reviewed weekly. It keeps the readership tight and lets us write more openly than a public newsletter ever could.

Does the brief pitch Innovation Park services?

No. The brief surfaces patterns from across 1,000+ company audits. The diagnostic and consulting offers live on the main site (SIGNAL Diagnostic, Partnership Revenue, EU Market Entry). The brief is the intelligence product, not the funnel.